Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease
- PMID: 27659458
- PMCID: PMC5117818
- DOI: 10.1016/j.jacc.2016.06.054
Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease
Abstract
Background: Intraindividual blood pressure (BP) fluctuates dynamically over time. Previous studies suggested an adverse link between greater visit-to-visit variability in systolic blood pressure (SBP) and various outcomes. However, these studies have significant limitations, such as a small size, inclusion of selected populations, and restricted outcomes.
Objectives: This study investigated the association of increased visit-to-visit variability and all-cause mortality, cardiovascular events, and end-stage renal disease (ESRD) in a large cohort of U.S. veterans.
Methods: From among 3,285,684 U.S. veterans with and without hypertension and normal estimated glomerular filtration rates (eGFR) during 2005 and 2006, we identified 2,865,157 patients who had 8 or more outpatient BP measurements. Systolic blood pressure variability (SBPV) was measured using the SD of all SBP values (normally distributed) in 1 individual. Associations of SD quartiles (<10.3, 10.3 to 12.7, 12.7 to 15.6, and ≥15.6 mm Hg) with all-cause mortality, incident coronary heart disease (CHD), stroke, and ESRD was examined using Cox models adjusted for sociodemographic characteristics, baseline eGFR, comorbidities, body mass index, SBP, diastolic BP, and antihypertensive medication use.
Results: Several sociodemographic variables (older age, male sex, African-American race, divorced or widowed status) and clinical characteristics (lower baseline eGFR, higher SBP and diastolic BP), and comorbidities (presence of diabetes, hypertension, cardiovascular disease, and lung disease) were all associated with higher intraindividual SBPV. The multivariable adjusted hazard ratios and 95% confidence intervals for SD quartiles 2 through 4 (compared with the first quartile) associated with all-cause mortality, CHD, stroke, and ESRD were incrementally higher.
Conclusions: Higher SBPV in individuals with and without hypertension was associated with increased risks of all-cause mortality, CHD, stroke, and ESRD. Further studies are needed to determine interventions that can lower SBPV and their impact on adverse health outcomes.
Keywords: hypertension; outcomes; visit-to-visit variability.
Published by Elsevier Inc.
Conflict of interest statement
None of the authors have relevant conflicts of interest.
Figures
 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                Comment in
- 
  
  Blood Pressure Variability: Insights From "Big Data".J Am Coll Cardiol. 2016 Sep 27;68(13):1387-1388. doi: 10.1016/j.jacc.2016.07.721. J Am Coll Cardiol. 2016. PMID: 27659459 No abstract available.
- 
  
  Reply: Systolic Blood Pressure Variability: Is Obstructive Sleep Apnea a Bigger Factor at Play?J Am Coll Cardiol. 2017 Feb 21;69(7):908-909. doi: 10.1016/j.jacc.2016.11.053. J Am Coll Cardiol. 2017. PMID: 28209233 No abstract available.
- 
  
  Systolic Blood Pressure Variability: Is Obstructive Sleep Apnea a Bigger Factor at Play?J Am Coll Cardiol. 2017 Feb 21;69(7):908. doi: 10.1016/j.jacc.2016.10.081. J Am Coll Cardiol. 2017. PMID: 28209234 No abstract available.
References
- 
    - Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics--2016 update: a report from the American Heart Association. Circulation. 2016;133:e38–e360. - PubMed
 
- 
    - James PA, Oparil S, Carter BL, et al. 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults. JAMA. 2014;311:507–20. - PubMed
 
- 
    - Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827–38. - PubMed
 
- 
    - Perry HM, Jr, Miller JP, Fornoff JR, et al. Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension. 1995;25:587–94. - PubMed
 
- 
    - Stokes J, 3rd, Kannel WB, Wolf PA, D'Agostino RB, Cupples LA. Blood pressure as a risk factor for cardiovascular disease. The Framingham Study--30 years of follow-up. Hypertension. 1989;13:I13–8. - PubMed
 
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
- Research Materials
- Miscellaneous
 
        